"Tweeting Growers"

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Surprises from Royal Van Zanten during Chrysanthemum Trials Colombia

The cut chrysanthemum trials are taking place in Colombia from 30 August to 3 September (week 35). This is a week-long collaborative initiative between ten breeding companies at which business partners and customers can find out about the latest developments across the entire spray, disbudded, and Santini range. "At our Flores Silvestres La Ceja site in Colombia, we will be shining the spotlight on lots of new products and, as in previous years, we will once again have a surprise up our sleeves for visitors," the company announces. 

Over the past year, they have been far from idle in terms of range development and are proud of the novelties and highlights. "Among other things, we are delighted to present these three newcomers:

Amalita: a bright pink disbudded chrysanthemum with a large, 14 cm diameter flower. Its contemporary shape and color are a perfect match for the current trend and demand for large flowers for bouquets. The color provides an extra touch of flair, making it suitable for many arrangements throughout the whole year. Besides its stunning looks, this disbudded variety brings the consumer extra joy with its guaranteed long vase life," they explain. 

Nevada and Espuma: In the white segment, Royal Van Zanten is presenting two newcomers during the flower trials. These white chrysanthemums are perfect for dyeing and can be grown both as spray and disbudded flowers. Nevada is a bright white disbudded variety with pretty, full, round flowers. Espuma is creamy white and is presented as a disbudded chrysanthemum with large, star-shaped flowers. These new introductions will beautifully complement our regular white chrysanthemum range.

For more information:
Royal Van Zanten
Lavendelweg 15, Rijsenhout
P.O. Box 265, 1430 AG Aalsmeer
The Netherlands
Tel: +31(0)297 38 70 00

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.